Developing our product portfolio with new therapies is increasing overall medical health of Kazakhstan.
A lot of companies that are interested in out-licensing of their products to Kazakhstan and other CIS states approached us. Also in many cases some opinion leaders mentioned that there is a need for a particular pharmaceutical and ask if we can bring it to Kazakhstan. In-licensing is priority for Imexpharma. We are interested in in-licensing so much mainly because it can bring needed products to Kazakhstan and because it will allow us to oversee all aspects of pharmaceutical product entry into Kazakhstan.
Although we are mainly focused on original and new products, we are also interested to consider all opportunities for partnership in this field.